Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 28:15:1405108.
doi: 10.3389/fneur.2024.1405108. eCollection 2024.

Effects of immune cells on ischemic stroke and the mediating roles of metabolites

Haoxiang Hu  1 , Mi Zhou  1 , Yunhan Zhao  1 , Jiesheng Mao  1 , Xiaokai Yang  1
Affiliations

Effects of immune cells on ischemic stroke and the mediating roles of metabolites

Haoxiang Hu et al. Front Neurol. .

Abstract

Objective: Previous studies have not shown an association between IgD-CD24-B-cell absolute count (IgD-CD24-AC) and ischemic stroke (IS). Our study aimed to assess the causal effect of IgD-CD24-AC on IS and to explore the role of ascorbic acid 2-sulfate (AA2S) as a potential mediator.

Methods: Our study was based on the largest available genome-wide association study (GWAS). Inverse variance weighting (IVW), MR-Egger, weighted median (WMN), simple mode, and weighted mode methods were used to assess causal effects, with IVW as the primary outcome. Subsequently, we further performed a two-step MR analysis to evaluate whether AA2S mediated this causal effect. In addition, several sensitivity analyses were conducted to evaluate heterogeneity, including Cochran's Q test, the MR-Egger intercept test, the MR-PRESSO global test, and the leave-one-out analysis.

Results: Using the IVW approach, the risk ratio of IgD-CD24-AC to IS was estimated to be 1.216 (95% CI = 1.079-1.371, p = 0.001). This result was supported by the WMN method (OR = 1.204, 95% CI = 1.020-1.421, p = 0.028) and the MR-Egger method (OR = 1.177, 95% CI = 0.962-1.442, p = 0.133). We also observed the same trend with the simple model and weighted model. Furthermore, the proportion of genetically predicted IgD-CD24-AC mediated through AA2S levels was 3.73%.

Conclusion: Our study revealed a causal relationship between IgD-CD24-AC and IS, a small part of which was mediated by AA2S. These findings offer critical insights for developing immune-targeted therapies in the future and lay a strong foundation for advancements in precision medicine.

Keywords: AA2S; IgD-CD24-AC; Mendelian randomization; immunology; ischemic stroke; metabolite.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The flowchart of our MR analysis. IgD-CD24-AC, IgD-CD24-B-Cell absolute count, AA2S, Ascorbic Acid 2-Sulfate.
Figure 2
Figure 2
Graphs illustrate the associations examined in this study. (A) Total effect “beta. All” of IgD-CD24-AC with ischemic stroke. (B) Total effect de-composed as (i) mediated effect using a two-step approach “beta12” = beta1 × beta2 (where “beta1” is the total effect of IgD-CD24-AC on AA2S and “beta2” is the effect of AA2S on ischemic stroke effect) (ii) direct effect = “total effect” − “mediated effect” (beta. All-beta12). The mediated ratio is the indirect effect divided by the total effect. IgD-CD24-AC, IgD-CD24-B Cell absolute count, AA2S, Ascorbic Acid 2-Sulfate.
Figure 3
Figure 3
Scatter plot of genetic association between IgD-CD24-AC, AA2S, and IS. (A) Association of IgD-CD24-AC with IS; (B) Association of IgD-CD24-AC with AA2S; (C) Association of AA2S with IS. The slope and direction of the straight line represent the magnitude and direction of the causal relationship. IgD-CD24-AC, IgD-CD24-B Cell absolute count, AA2S, Ascorbic Acid 2-Sulfate.
Figure 4
Figure 4
Forest plot of genetic association between IgD-CD24-AC and IS.
Figure 5
Figure 5
Forest plot to visualize the causal effects of AA2S with IgD-CD24-AC and ischemic stroke. IgD-CD24-AC, IgD-CD24-B Cell absolute count, AA2S, Ascorbic Acid 2-Sulfate.
Figure 6
Figure 6
Schematic diagram of the AA2S mediation effect. IgD-CD24-AC, IgD-CD24-B Cell absolute count, AA2S, Ascorbic Acid 2-Sulfate.
See this image and copyright information in PMC

References

    1. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (review). Int J Mol Med. (2022) 49:15. doi: 10.3892/ijmm.2021.5070, PMID: - DOI - PMC - PubMed
    1. Hasan TF, Hasan H, Kelley RE. Overview of acute ischemic stroke evaluation and management. Biomedicines. (2021) 9:1486. doi: 10.3390/biomedicines9101486, PMID: - DOI - PMC - PubMed
    1. Feske SK. Ischemic stroke. Am J Med. (2021) 134:1457–64. doi: 10.1016/j.amjmed.2021.07.027 - DOI - PubMed
    1. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. (2016) 388:761–75. doi: 10.1016/S0140-6736(16)30506-2, PMID: - DOI - PubMed
    1. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. . Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. (2021) 20:795–820. doi: 10.1016/S1474-4422(21)00252-0, PMID: - DOI - PMC - PubMed

LinkOut - more resources